Veravas Inc. develops diagnostic technology and testing solutions, including its proprietary VeraBIND platform, designed to reduce laboratory test interference and detect hard-to-find biomarkers. The company primarily serves clinicians, researchers, and patients by providing tools and assays focused on the early detection of complex conditions such as Alzheimer's disease and other dementias.
Subscribe to see Verava Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Verava Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $5,000 in September 2025. Xcout tracks 6 named people at Verava Inc., including Luc Vanhal (Chief Operating Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.